← Browse by Condition
Medical Condition

pilonidal sinus

Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for pilonidal sinus sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — pilonidal sinus Clinical Trials

How many clinical trials are currently recruiting for pilonidal sinus?
ClinicalMetric currently tracks 4 actively recruiting clinical trials for pilonidal sinus, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 4. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pilonidal sinus?
pilonidal sinus research spans Phase 2 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pilonidal sinus clinical trial?
Eligibility criteria for pilonidal sinus trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Top Sponsors
Medipol University 1 trial
University of Pennsylvania 1 trial
Royal College of Surgeons, Ireland 1 trial
Albert Schweitzer Ziekenhuis, Netherlands 1 trial

Recruiting Clinical Trials

NCT07534488
Recruiting
Sacral Erector Spinae Plane Block in Pilonidal Sinus Surgery
Enrollment
60 pts
Location
Turkey (Türkiye)
Sponsor
Medipol University
View Trial →
NCT06286397 Phase 2
Recruiting
Topical Anti-Androgens in Pilonidal Sinus Disease
Enrollment
75 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT06647290
Recruiting
ENVELOP: Wound Care Following Pilonidal Sinus Surgery
Enrollment
200 pts
Location
Ireland
Sponsor
Royal College of Surgeons, Ire...
View Trial →
NCT06683274
Recruiting
Bascom Cleft Lift for Primary Wound Healing in Complex and Recurrent Sacrococcygeal Pilonidal Sinus Disease
Enrollment
58 pts
Location
Netherlands
Sponsor
Albert Schweitzer Ziekenhuis, ...
View Trial →

Related Conditions

sacral erector spinae plane block (1) pilonidal disease (1) pilonidal disease of natal cleft (1) pilonidal cyst (1) wound healing (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology